Immunohistochemical detections of EGFR status in NSCLC

Immunohistochemical detections of EGFR status in NSCLC

Background and objective Patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR) respond well to EGFR-tyrosine kinase inhibitor therapy. Immunohistochemistry (IHC) is a simple and widely used technique in clinical pathology laboratories. IH...

Full description

Bibliographic Details
Main Authors: Jie WANG, Chang LIU, Diansheng ZHONG, Dongbo XU, Chao NING, Qing MA
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Epidermal growth factor receptor
Mutation
Immunohistochemistry
Liquid chip technology
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.01

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.01

Similar Items